QTTB Q4 2019 Earnings — Q32 Bio Inc. Revenue & Financial Results | Market Cap Arena

QTTBQ32 Bio Inc.

$83M

Q4 2019 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$563,000-42.6% YoY

Gross Profit

$00.0% margin

Operating Income

-$26M-4539.8% margin

Net Income

-$24M-4292.5% margin

EPS (Diluted)

$-9.87

QoQ Revenue Growth

+27.7%

Cash Flow

Operating Cash Flow

-$26M

Free Cash Flow

-$30M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$311M

Total Liabilities

$52M

Stockholders' Equity

$259M

Cash & Equivalents

$54M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$563,000	$980,000	-42.6%
Gross Profit	$0	$0	—
Operating Income	-$26M	-$20M	-25.4%
Net Income	-$24M	-$19M	-27.2%